Skip to main content
. 2022 Sep 29;13:977539. doi: 10.3389/fphar.2022.977539

FIGURE 1.

FIGURE 1

Network Pharmacological Analysis of Ginsenoside Rb1 and CK. (A) Topological network of key targets of ginsenoside Rb1 in the treatment of gastric cancer. (B) Topological network of key targets of ginsenoside CK in the treatment of gastric cancer. (C) GO biological function enrichment analysis of key targets of ginsenoside Rb1 in the treatment of gastric cancer. (D) KEGG pathway enrichment analysis of key targets of ginsenoside Rb1 in the treatment of gastric cancer. (E) GO biological function enrichment analysis of key targets of ginsenoside CK in the treatment of gastric cancer. (F) KEGG pathway enrichment analysis of key targets of ginsenoside CK in the treatment of gastric cancer.